Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.

Literature DB >> 22042963

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.

Tommaso M De Pas¹, Monica Giovannini, Michela Manzotti, Giuseppe Trifirò, Francesca Toffalorio, Chiara Catania, Lorenzo Spaggiari, Roberto Labianca, Massimo Barberis.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 22042963 DOI： 10.1200/JCO.2011.36.2251

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

Review 1. Treatment of lung large cell neuroendocrine carcinoma.

Authors: Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal: Tumour Biol Date: 2016-03-04

2. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.

Authors: Minglei Zhuo; Yanfang Guan; Xue Yang; Lingzhi Hong; Yuqi Wang; Zhongwu Li; Runzhe Chen; Hussein A Abbas; Lianpeng Chang; Yuhua Gong; Nan Wu; Jia Zhong; Wenting Chen; Hanxiao Chen; Zhi Dong; Xiang Zhu; Jianjie Li; Yuyan Wang; Tongtong An; Meina Wu; Ziping Wang; Jiayin Wang; Emily B Roarty; Waree Rinsurongkawong; Jeff Lewis; Jack A Roth; Stephen G Swisher; J Jack Lee; John V Heymach; Ignacio I Wistuba; Neda Kalhor; Ling Yang; Xin Yi; P Andrew Futreal; Bonnie S Glisson; Xuefeng Xia; Jianjun Zhang; Jun Zhao
Journal: Clin Cancer Res Date: 2019-11-06 Impact factor: 12.531

3. A marked response to icotinib in a patient with large cell neuroendocrine carcinoma harboring an EGFR mutation: A case report.

Authors: Yuehong Wang; Yi Hong Shen; Shanni Ma; Jianying Zhou
Journal: Oncol Lett Date: 2015-06-22 Impact factor: 2.967

4. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

Authors: Natasha Rekhtman; Maria C Pietanza; Matthew D Hellmann; Jarushka Naidoo; Arshi Arora; Helen Won; Darragh F Halpenny; Hangjun Wang; Shaozhou K Tian; Anya M Litvak; Paul K Paik; Alexander E Drilon; Nicholas Socci; John T Poirier; Ronglai Shen; Michael F Berger; Andre L Moreira; William D Travis; Charles M Rudin; Marc Ladanyi
Journal: Clin Cancer Res Date: 2016-03-09 Impact factor: 12.531

5. De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.

Authors: Xiuning Le; Neelam V Desai; Adnan Majid; Rebecca S Karp; Mark S Huberman; Deepa Rangachari; Michael S Kent; Sidharta P Gangadharan; Erik Folch; Paul A VanderLaan; Daniel B Costa
Journal: Lung Cancer Date: 2015-02-07 Impact factor: 5.705

10. Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature.

Authors: Yasuhiro Sakai; Takashi Yamasaki; Yoshito Kusakabe; Daisuke Kasai; Yoshikazu Kotani; Yoshihiro Nishimura; Tomoo Itoh
Journal: Multidiscip Respir Med Date: 2013-07-18

Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.

Review 1. Treatment of lung large cell neuroendocrine carcinoma.

2. The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.

3. A marked response to icotinib in a patient with large cell neuroendocrine carcinoma harboring an EGFR mutation: A case report.

4. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

5. De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.

Review 6. Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.

Review 7. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments.

8. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.

9. Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.

10. Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature.